While patients with CANDLE were hyperresponsive to IFN-α stimulation before treatment with baricitinib (7), most patients with SAVI had maximal STAT1 phosphorylation and did not respond to IFN-α stimulation (9). Here, STAT1 is linked to STING-associated vasculopathy with onset in infancy.